Open-Label Placebo (OLP)
Showing 1 - 25 of >10,000
Acute Pain Trial in Basel (OLP-injection, Scripted Evidence-based treatment rationale, Experimental model of acute pain)
Recruiting
- Acute Pain
- OLP-injection
- +2 more
-
Basel, SwitzerlandUniversity Hospital of Basel (USB); Department of Anaesthesiolog
Apr 5, 2023
Opioid Dependence, Opioid Abuse Trial (Open Label Placebo, Patient medication as standardly prescribed)
Not yet recruiting
- Opioid Dependence
- Opioid Abuse
- Open Label Placebo
- Patient medication as standardly prescribed
- (no location specified)
Feb 14, 2022
Multiple Sclerosis, Fatigue Trial in Birmingham (OLP treatment, Usual care, Expectancy Group)
Completed
- Multiple Sclerosis
- Fatigue
- OLP treatment
- +2 more
-
Birmingham, Alabama
- +1 more
Jan 31, 2022
Postoperative Pain Trial in Basel (Open-Label Placebo, treatment as usual)
Recruiting
- Postoperative Pain
- Open-Label Placebo
- treatment as usual
-
Basel, SwitzerlandUniversity Hospital of Basel, Department of Anesthesia
Oct 27, 2021
Chronic Pain Trial (Placebo)
Not yet recruiting
- Chronic Pain
- Placebo
- (no location specified)
Jul 17, 2023
Pain, Postoperative Trial in Lausanne (Placebo)
Not yet recruiting
- Pain, Postoperative
- Placebo
-
Lausanne, Vaud, SwitzerlandCentre de Médecine Intégrative et Complémentaire, Service d'anes
Oct 24, 2023
Opioid-use Disorder, Opioid-Related Disorders Trial in Baltimore (Open-Label Placebo (OLP))
Completed
- Opioid-use Disorder
- Opioid-Related Disorders
- Open-Label Placebo (OLP)
-
Baltimore, MarylandMaryland Methadone Treatment Center
Aug 7, 2020
Neuropathic Pain Trial in Lausanne (Hypnosis, Open label )
Recruiting
- Neuropathic Pain
- Hypnosis
- Open label placebo
-
Lausanne, SwitzerlandLausanne University Hospital (CHUV)
Jun 28, 2022
The Regulatory Role of Immune Response in Oral Lichen Planus
Recruiting
- Oral Lichen Planus
- Control
- +2 more
-
Beijing, ChinaPeking University Third Hospital
Aug 9, 2023
Metastatic Cancers, Fatigue Trial in Houston (Psychoeducational Intervention, Open Label Placebo, Psychoeducational
Not yet recruiting
- Metastatic Cancers
- Fatigue
- Psychoeducational Intervention
- +2 more
-
Houston, TexasMD Anderson Cancer Centerr
Oct 10, 2023
Malaria Trial (Meplazumab for Injection)
Not yet recruiting
- Malaria
- Meplazumab for Injection
- (no location specified)
Sep 13, 2023
Open Angle Glaucoma Trial in Geneva (contact lens sensor (CLS) SENSIMED Triggerfish®)
Terminated
- Open Angle Glaucoma
- contact lens sensor (CLS) SENSIMED Triggerfish®
-
Geneva, SwitzerlandUniversity Hospital Geneva
May 16, 2023
Motion Sickness Trial in Santa Monica (Tradipitant)
Recruiting
- Motion Sickness
-
Santa Monica, CaliforniaSanta Monica Clinical Trials
Nov 13, 2023
Pulmonary Hypertension, Interstitial Lung Disease Trial (LIQ861)
Not yet recruiting
- Pulmonary Hypertension
- Interstitial Lung Disease
- LIQ861
- (no location specified)
Nov 10, 2023
Test Anxiety Trial in Basel (information about "No treatment group", imaginary pill technique, open label )
Completed
- Test Anxiety
- information about "No treatment group"
- +2 more
-
Basel, SwitzerlandDivision of Clinical Psychology and Psychotherapy, Department of
Jan 26, 2022
Safety Issues Trial (Nicotinamide Riboside)
Recruiting
- Safety Issues
- Nicotinamide Riboside
-
Bergen, Vestland, NorwayHaukeland University Hospital
Nov 25, 2022
Hypertension Trial in Hosszuheteny (Nebivolol 5 mg, Ramipril 2.5/5/10 mg)
Recruiting
- Hypertension
- Nebivolol 5 mg
- Ramipril 2.5/5/10 mg
-
Hosszuheteny, HungaryA & P Kft.
Oct 23, 2023
Alpha 1-Antitrypsin Deficiency, Emphysema Trial (INBRX-101)
Not yet recruiting
- Alpha 1-Antitrypsin Deficiency
- Emphysema
- (no location specified)
May 31, 2023
Thyroid Eye Disease, TED Trial in Shanghai (IBI311)
Recruiting
- Thyroid Eye Disease, TED
-
Shanghai, Shanghai, ChinaNinth People's Hospital Affiliated to Shanghai Jiao Tong Univers
Nov 9, 2023
Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
Jul 31, 2023
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- Ceftibuten
- (no location specified)
Nov 27, 2023
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Boston (CABA-201)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- CABA-201
-
Boston, MassachusettsMassachusetts General Hospital
Nov 7, 2023
Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, TBS-DMPFC)
Not yet recruiting
- Treatment Resistant Depression
- Active TBS-DLPFC
- TBS-DMPFC
-
Stanford, CaliforniaStanford University
Sep 18, 2023